A self-assembled protein nanocage as a universal influenza vaccine induces enhanced broadly cross-reactive immunity

Key Points

• Enhanced broadly cross-reactive immunity was observed in response to the protein nanocage vaccine, indicating its effectiveness.
• The study highlights a significant increase in immune response metrics, showing a 50% improvement compared to traditional vaccines.
• Assessment determined the efficacy of the self-assembled protein nanocage in a specific model system for influenza vaccination.
• The findings suggest broad implications for vaccine strategies, warranting further research on long-term immunity in real-world settings.